PhaseⅠ Project of Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Successfully Passed the Completion Acceptance

2024-04-18

In the first ten days of April 2024, the first-phase project construction of Hubei Tianshu Pharmaceutical Co., Ltd. ("Tianshu Pharmaceutical"), a subordinate production base of Nanjing Vcare, successfully passed the completion acceptance of safety, environmental protection upon completion, and control effect of occupational disease hazards. This marked that Tianshu Pharmaceutical entered the formal production stage.

The expert group's review concluded that the phaseⅠproject of Tianshu Pharmaceutical had complete procedures for safety, environmental protection, and control of occupational disease hazards. The pollution prevention and control measures within the scope of the project acceptance had all been implemented in accordance with the project's environmental impact assessment documents, the approval of the environmental impact assessment, and the requirements for non-significant matters. The emissions of various pollutants all met the relevant standard requirements and conformed to the conditions of environmental protection upon completion. Therefore, the expert group agreed that the project passed the acceptance of safety, environmental protection upon completion, and control of occupational disease hazards.

Subsequently, Tianshu Pharmaceutical will further strengthen the sense of responsibility, improve various systems such as safety management, environmental protection management, and occupational disease protection, strengthen daily management, implement the system of person-in-charge responsibility, do a good job in keeping records of inspections, operation records of environmental protection treatment equipment, etc., so as to promote the sustainable development of the enterprise.

Prev

The Application for Clinical Trial of a Class 1 New Drug Developed by Nanjing Vcare to Assist its CDMO Partners has been Officially Accepted

Next

Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Was Approved for the "Drug Production License", Adding a New Engine to the Whole-Industrial-Chain Layout